Bhatla B, Moore H L, Nolph K D
Division of Nephrology, University of Missouri-Columbia, USA.
Adv Perit Dial. 1995;11:101-5.
The use of creatinine clearance for adequacy of continuous ambulatory peritoneal dialysis (CAPD) requires consideration of the fact that a significant fraction of residual renal creatinine clearance is contributed by tubular secretion. We analyzed 123 peritoneal dialysis (PD) patients and corrected the residual renal creatinine clearance by averaging renal creatinine and urea clearance to estimate the glomerular filtration rate (GFR). Modified total creatinine clearance (peritoneal plus estimated renal GFR) was compared with total creatinine clearance (peritoneal plus total renal creatinine clearance). Modified and total creatinine clearances were not significantly different in patients with a total creatinine clearance less than 60 L/week/1.73 m2 body surface area (BSA), but a significantly lower modified total creatinine clearance was seen with patients having greater than 60 L/week/1.73 m2 BSA of total creatinine clearance. The correlation was better between KT/V and modified total creatinine clearance (r = 0.74) as compared to KT/V and total creatinine clearance (r = 0.67). We suggest that if creatinine clearance is used for peritoneal dialysis (PD) adequacy, the contribution of residual renal function should be calculated as the average of renal creatinine and urea clearance, thus estimating creatinine clearance only by the GFR. Further long-term studies are needed to confirm that modification of total creatinine clearance will better predict clinical outcome.
使用肌酐清除率来评估持续性非卧床腹膜透析(CAPD)的充分性时,需要考虑到残余肾肌酐清除率的很大一部分是由肾小管分泌所致。我们分析了123例腹膜透析(PD)患者,并通过平均肾肌酐清除率和尿素清除率来校正残余肾肌酐清除率,以估算肾小球滤过率(GFR)。将修正后的总肌酐清除率(腹膜清除率加估算的肾GFR)与总肌酐清除率(腹膜清除率加总肾肌酐清除率)进行比较。在总肌酐清除率低于60L/周/1.73m²体表面积(BSA)的患者中,修正后的和总的肌酐清除率无显著差异,但在总肌酐清除率大于60L/周/1.73m² BSA的患者中,修正后的总肌酐清除率明显较低。与KT/V和总肌酐清除率(r = 0.67)相比,KT/V与修正后的总肌酐清除率之间的相关性更好(r = 0.74)。我们建议,如果使用肌酐清除率来评估腹膜透析(PD)的充分性,残余肾功能的贡献应以肾肌酐清除率和尿素清除率的平均值来计算,从而仅通过GFR来估算肌酐清除率。需要进一步的长期研究来证实修正总肌酐清除率能否更好地预测临床结局。